BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3965374)

  • 21. Carcinoma of the endometrium and hormonal receptors.
    Satyaswaroop PG; Zaino RJ; Mortel R
    Cancer Treat Res; 1989; 49():71-92. PubMed ID: 2577204
    [No Abstract]   [Full Text] [Related]  

  • 22. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
    Thurzó L; Sas M; Falkay G
    Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cytoplasmic estrogen and progestin receptors in uterine myomatous tissue and serum estradiol and progesterone levels in women with uterine myoma].
    Chen GA
    Zhonghua Fu Chan Ke Za Zhi; 1984 Apr; 19(2):88-92. PubMed ID: 6468092
    [No Abstract]   [Full Text] [Related]  

  • 24. Sex steroid receptors in endometrial cancer.
    Chambers JT
    Yale J Biol Med; 1988; 61(4):339-50. PubMed ID: 3055700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.
    Quinn MA; Cauchi M; Fortune D
    Gynecol Oncol; 1985 Jul; 21(3):314-9. PubMed ID: 3159630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oestrogen and progestin receptors as prognostic indicators in endometrial cancer. A review of the literature.
    Kauppila A
    Acta Oncol; 1989; 28(4):561-6. PubMed ID: 2675940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal aspects of endometrial cancer.
    Sutton G
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):69-73. PubMed ID: 2102309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent rhabdomyosarcoma after 25 years: a possible association with estrogen and progestogen therapy.
    Zacharin M; Waters K; Chow CW; Crock P; McKelvie P
    J Pediatr Hematol Oncol; 1997; 19(5):477-81. PubMed ID: 9329475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterine endolymphatic stromal myosis: a collaborative study.
    Piver MS; Rutledge FN; Copeland L; Webster K; Blumenson L; Suh O
    Obstet Gynecol; 1984 Aug; 64(2):173-8. PubMed ID: 6738952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
    Ehrlich CE; Young PC; Cleary RE
    Am J Obstet Gynecol; 1981 Nov; 141(5):539-46. PubMed ID: 6457531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steroid hormone receptors in adenocarcinoma of the endometrium.
    Hunter RE; Longcope C; Jordan VC
    Gynecol Oncol; 1980 Oct; 10(2):152-61. PubMed ID: 7461481
    [No Abstract]   [Full Text] [Related]  

  • 32. Hormonal and cytotoxic chemotherapy for endometrial carcinoma. Steroid receptors in the selection of appropriate therapy.
    Kauppila A; Friberg LG
    Acta Obstet Gynecol Scand Suppl; 1981; 101():59-64. PubMed ID: 6946673
    [No Abstract]   [Full Text] [Related]  

  • 33. Hormonal treatment of endometrial cancer: past, present and future.
    Podczaski E; Mortel R
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):469-89. PubMed ID: 11476566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of progestins in the treatment of breast cancer.
    Blumenschein GR
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):7-10. PubMed ID: 6230722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
    Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
    Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of endocrine responsive breast and endometrial carcinoma using steroid hormone receptors.
    Wittliff JL; Day TG; Dean WL; Allegra JC
    Prog Clin Biol Res; 1988; 276():11-41. PubMed ID: 3051018
    [No Abstract]   [Full Text] [Related]  

  • 37. Estrogen and progesterone receptors in uterine leiomyomas.
    Marugo M; Centonze M; Bernasconi D; Fazzuoli L; Berta S; Giordano G
    Acta Obstet Gynecol Scand; 1989; 68(8):731-5. PubMed ID: 2631544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
    Feng YJ; Zhang XY
    Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors.
    Katz L; Merino MJ; Sakamoto H; Schwartz PE
    Gynecol Oncol; 1987 Jan; 26(1):87-97. PubMed ID: 3792939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
    Ehrlich CE; Young PC; Stehman FB; Sutton GP; Alford WM
    Am J Obstet Gynecol; 1988 Apr; 158(4):796-807. PubMed ID: 2966586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.